- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03094858
Evaluation of a Smartphone Intervention to Reduce Sedentary Behavior (SMARTpath)
June 10, 2021 updated by: University of Oklahoma
Participants (N = 300) will be randomly assigned to: 1) an equipment-only comparison group that receives a smartphone and an activity monitor wristband but does not receive smartphone intervention prompts, or 2) the intervention group who will receive an activity monitor wristband that works in conjunction with a smartphone to reduce sedentary time via smartphone prompts during prolonged sedentary bouts.
All participants will be provided with a Fitbit® wristband activity monitor and an Android smartphone on the same day of the week (i.e., Mondays).
Participants will complete a 1-week baseline accelerometer and EMA period prior to the start of the intervention.
Participants will be followed for 26 weeks after the intervention begins with follow-up visits at 6, 13, and 26 weeks.
The primary outcome will be accelerometer-measured time spent in sedentary activity.
Sedentary breaks, total active time, and time spent in light, moderate, and vigorous activity will be additionally evaluated as outcomes.
Contextual variables and potential treatment mechanisms will be assessed via traditional questionnaire measurement and daily random EMAs at baseline and all follow-up visits.
Brief smartphone-based daily diary assessments will be completed daily for the duration of the study.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- A score of ≥ 4 on the REALM-SF85 indicating > 6th grade English literacy level, must be at least 18 years of age
- A BMI ≥ 25 (overweight/obese), not meeting current physical activity guidelines as measured by the 7-Day Physical Activity Recall
- Do not have a contraindication for physical activity based on the Physical Activity Readiness Questionnaire (PAR-Q)
- Able to attend all study visits, and possess a valid home address and a functioning telephone number.
Exclusion Criteria:
- Participants who have physical disabilities that restrict lower limb function and/or reading skills below a 7th grade reading level.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Comparison group
Equipment only comparison group will use Smartphone and Wristband to monitor sedentary behavior
|
Wristband will monitor activity of all participants
Other Names:
Smartphone will be used to monitor activity but prompts will not be given to randomly selected participants
Other Names:
|
|
Experimental: Intervention group
Intervention group will receive prompts from Smartphone to reduce sedentary behavior using information from Wristband
|
Wristband will monitor activity of all participants
Other Names:
Smartphone will be used to prompt randomly selected participants in intervention group to be active
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accelerometer-measured sedentary time
Time Frame: One week
|
Total accelerometer-measured time spent in sedentary activity
|
One week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accelerometer-measured sedentary breaks
Time Frame: 26 weeks
|
Accelerometer-measured time spent in sedentary activity
|
26 weeks
|
|
Accelerometer-measured total active time
Time Frame: 26 weeks
|
Total active time
|
26 weeks
|
|
Accelerometer-measured time spent in light, moderate, and vigorous activity
Time Frame: 26 weeks
|
Total time spent in light, moderate, and vigorous activity
|
26 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Darla Kendzor, PhD, University of Oklahoma
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2019
Primary Completion (Anticipated)
April 1, 2020
Study Completion (Anticipated)
April 1, 2020
Study Registration Dates
First Submitted
February 16, 2017
First Submitted That Met QC Criteria
March 23, 2017
First Posted (Actual)
March 29, 2017
Study Record Updates
Last Update Posted (Actual)
June 11, 2021
Last Update Submitted That Met QC Criteria
June 10, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 7092
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk Reduction Behavior
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedRisk ReductionSouth Africa
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompleted
-
University of California, San FranciscoUniversity of MiamiCompletedRisk ReductionUnited States
-
Colorado State UniversityUniversity of Colorado, Denver; United States Department of Agriculture (USDA) and other collaboratorsRecruitingMental Health Wellness | Lifestyle Risk Reduction | Family ResearchUnited States
-
Hadassah Medical OrganizationCompletedHealth Behavior | Food Habits | Lifestyle Risk ReductionIsrael
-
Istituto per la Ricerca e l'Innovazione BiomedicaFondazione Don Carlo Gnocchi Onlus; Universita degli Studi di Palermo; Medilink...RecruitingHealth Promotion | Life Style, Healthy | Risk ReductionItaly
-
National Taiwan University HospitalCompletedLifestyle Risk Reduction | Elderly Adults | Community DwellingTaiwan
-
Hadassah Medical OrganizationHebrew University of JerusalemNot yet recruitingHealth Behavior | Food Habits | Lifestyle Risk Reduction
-
University of California, San FranciscoUniversity of California, Berkeley; National Institute of Environmental Health... and other collaboratorsCompletedRisk Reduction | Children, Only | Environmental ExposureUnited States
-
University of PittsburghNational Institute of Environmental Health Sciences (NIEHS)RecruitingAsthma Exacerbation | Childhood Asthma | Air Pollution, Risk Reduction Behaviors | Asthma ControlUnited States
Clinical Trials on Wristband
-
Ataturk UniversityCompletedPostoperative ComplicationsTurkey
-
China Medical University HospitalUnknownGastroesophageal Reflux DiseaseTaiwan
-
Wake Forest University Health SciencesCompleted
-
University of Alabama at BirminghamCompleted
-
Rush University Medical CenterTerminatedPosttraumatic Stress DisorderUnited States
-
Columbia UniversityTerminatedGastro Intestinal BleedingUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; BiosencyActive, not recruitingChronic Obstructive Pulmonary DiseaseFrance
-
The Cleveland ClinicRecruitingPregnancy Related | Congenital Heart Disease | Congenital Cardiomyopathy | Congenital Vascular DisorderUnited States
-
NeosensoryNot yet recruiting